Back to results
US 2016/0101158 A1Published application
Peptide therapeutics and methods for using same
OwnerD. Travis WILSONinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of GLP-1, and/or naturally or artificially occurring variants or analogues of GLP-1, or pharmaceutically acceptable salts thereof, alone or in combination with one or more active agents (e.g., an aromatic-cationic peptide such as D-Arg-2′6′-Dmt-Lys-Phe-NH2).
Claims27
A composition comprising GLP-1 alone or in combination with one or more active agents (e.g., an aromatic-cationic peptide such as D-Arg-2′6′-Dmt-Lys-Phe-NH2) or one or more aromatic-cationic peptides disclosed in section II or Table 1.
Dependencies are inferred from the claim text.